Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in ...

A heart failure polypill was not only associated with better adherence to guideline-directed medicines but also better ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...

Function Health's $300 million fundraise, K Health's primary care play, new AI startup from Berkeley, and more.

N EW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

Please provide your email address to receive an email when new articles are posted on . Interaction of heart disease with kidney disease may be present at subclinical stages. Echocardiographic ...

Following the course of lung function in treatment-naïve patients, researchers found that lung function decline does not accelerate prior to mechanical ventilation. Patterns in the decline of lung ...

The REMODEL trial testing semaglutide’s efficacy in patients with CKD and T2DM also employed MRI, transcriptomics, blood and urine samples, and kidney biopsies to clarify the drug’s effects.

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and ...

Kidney disease disproportionately affects Black communities, with Black Americans nearly four times as likely to develop ...

In an exclusive guest post, Lucas Daniel Cuatrecasas, JD, the author of a new trademark law study forthcoming in the New York University Law Review, outlines why failure to function has become a ...